Mersana Therapeutics, Inc. earnings per share and revenue

MRSN earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.17 USD which accounts for 47.58% surprise. Company revenue for the same period amounts to 12.60 M USD despite the estimated figure of 7.53 M USD. Estimated earnings per share for the next quarter are -0.15 USD, and revenue is expected to reach 7.64 M USD. Also watch annual changes over time to get a bigger picture of MRSN earnings per share and revenue dynamics.